5 nominees · 5 ballot items.
Elect five directors; ratify Rosenberg Rich Baker Berman, P.A. as independent auditor for fiscal 2027; approve, on an advisory basis, the compensation of the Company’s named executive officers (say-on-pay); hold an advisory vote on the frequency of future say-on-pay votes (1, 2 or 3 years); and approve an amendment to the 2024 Omnibus Incentive Compensation Plan to increase authorized shares by 530,000.
Elect five nominees named in this Proxy Statement (Steven L. Craig, Jeffrey R. Geygan, Mel Keating, Brian Quinn and Alberto Pérez-Jácome Friscione) as directors, each to hold office until the 2027 Annual Meeting and until their successors are elected and qualified.
Ratify the Audit Committee’s selection of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending February 28, 2027.
A non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (the overall compensation program, tables and related disclosure).
This proposal is a non-binding advisory vote (say-on-pay) asking stockholders to approve the Company’s disclosed compensation for its named executive officers. Management and the Compensation Committee seek this annual advisory endorsement to validate their compensation philosophy, which emphasizes performance-based pay, a mix of short- and long-term incentives, equity ownership guidelines, and clawback protections. The Committee argues that the structure aligns executive incentives with stockholder value by tying significant compensation to company performance and multi-year vesting of equity awards; it also notes use of market benchmarking and engagement with stockholders. Importantly, the vote is advisory and not binding on the Board, but management will consider the outcome when designing future pay programs. The Company discloses that certain discretionary incentives were suspended in fiscal 2026 and that a majority of LTIP awards are performance-based, signaling an attempt to calibrate incentives to recent business conditions. For governance-minded investors, key considerations include the non-binding nature of the vote, the details of performance metrics and vesting, potential dilution from equity awards, and the presence of safeguards such as clawback and anti-repricing provisions. The Board’s unanimous recommendation FOR the proposal reflects its view that the program is appropriately balanced to attract and retain executives while protecting stockholder interests; however, investors should weigh disclosure detail, historic pay-for-performance alignment, and the Company’s recent engagement and responsiveness to stockholder feedback when evaluating the merits of supporting the proposal.
An advisory vote for stockholders to indicate whether the Company should hold future say-on-pay votes every one, two, or three years (or abstain); the Board recommends one year.
This is a non-binding advisory proposal asking stockholders to choose the preferred interval—one, two, or three years—for future say-on-pay votes. Management’s case for an annual vote is that it provides timely, direct feedback on compensation policies disclosed each year, aligns with past practice since 2013, and improves the Board’s ability to interpret and respond to stockholder sentiment. The Board emphasizes that annual voting reduces ambiguity about whether a negative vote pertains to current-year disclosure or prior practices and that stockholders previously endorsed an annual frequency in 2020. The outcome is advisory; the option receiving the most votes will be deemed the stockholder preference, but the Board and Compensation Committee are not legally bound to adopt it. For investors, the key tradeoffs are between responsiveness (annual votes allow frequent engagement and quicker course corrections) and governance efficiency (less frequent votes reduce administrative load and may encourage longer-term perspective). The Board’s public rationale highlights investor engagement and transparency as primary drivers for recommending one year. Given the Company’s active outreach on compensation matters and recent governance updates (clawback policy, anti-repricing), an annual vote may be consistent with its intent to remain responsive to stockholders. However, some long-term investors prefer multi-year cycles to evaluate pay-for-performance over longer periods; such viewpoints are relevant when interpreting the advisory outcome and management’s intended responsiveness.
Approve an amendment to the Company’s 2024 Omnibus Incentive Compensation Plan to increase the number of shares authorized for issuance under the Plan by 530,000 shares (from 683,949 to 1,213,949 shares), to support future equity grant activity for retention, recruitment and incentive alignment.
This management proposal requests stockholder approval to amend the 2024 Omnibus Incentive Compensation Plan by increasing the shares authorized for issuance by 530,000 shares (raising the total from 683,949 to 1,213,949). Management and the Compensation Committee argue the increase is necessary to support anticipated equity grant activity over the next two to three years for retention, recruitment, and incentive alignment as the Company pursues growth and franchising objectives. The amendment would represent approximately 12.86% of outstanding shares as of the record date, so investors should weigh the dilutive effect against the benefits of aligning employee and executive interests with long-term stockholder value. The 2024 Plan includes governance protections described in the filing — minimum vesting periods, performance-based award requirements, anti-repricing without shareholder approval, and clawback provisions — which management cites to limit misuse and protect stockholders. The Board also notes that Nasdaq rules require shareholder-approved plans for equity compensation, so approval is necessary for ongoing equity grant flexibility. For investors evaluating the proposal, key considerations include the size of the requested increase relative to current run-rate of grants, historical usage of plan shares, expected dilution, and whether the design of future awards will be clearly disclosed with performance metrics that align pay to multi-year outcomes. Management’s unanimous recommendation FOR the amendment reflects its view that the additional capacity to grant equity is important to retain and attract talent in a competitive market while using awards selectively and with multi-year vesting to promote long-term value creation. If approved, Annex A becomes operative, updating Section 4.1 to reflect the increased share reserve and preserving the remainder of the plan terms.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 3.0% | 280,918 | $632K |
| 2 | Focus Partners Wealth | 2.1% | 200,020 | $450K |
| 3 | American Capital Advisory, LLC | 1.4% | 134,867 | $303K |
| 4 | THOMPSON DAVIS CO., INC. | 1.0% | 95,555 | $215K |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.0% | 92,051 | $207K |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 0.7% | 66,950 | $151K |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 0.6% | 56,078 | $126K |
| 8 | Leverty Financial Group, LLC | 0.4% | 40,371 | $91K |
| 9 | VANGUARD FIDUCIARY TRUST CO | 0.3% | 30,507 | $69K |
| 10 | Salvus Wealth Management, LLC | 0.3% | 23,567 | $53K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.